Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference Life Science Investing
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress Life Science Investing
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Life Science Investing
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference Life Science Investing
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses Life Science Investing
Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update Life Science Investing
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities Life Science Investing
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
